Michigan State University — Lansing, Michigan

Michigan State University is a clinical research site located in Lansing, Michigan, United States 48911.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Michigan State University has participated in 22 clinical trials with 4 currently active.

Therapeutic areas: Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors, Cerebrovascular Accident.

Sponsors: Novo Nordisk A/S, CoAxia, EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Michigan State University?

Michigan State University has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Michigan State University conducted?

Michigan State University has 22 clinical trials on record, with 4 currently active. Their work covers Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors, Cerebrovascular Accident.

Is Michigan State University accredited by Crixeo Health?

Yes — Michigan State University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Michigan State University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.